Literature DB >> 6134108

Experience with the Oxford tumour marker (Ca1) in serous fluids.

G Pallesen, F L Jepsen, J Hastrup, A Ipsen, N Hvidberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6134108     DOI： 10.1016/s0140-6736(83)92430-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.

Authors:  A K Ghosh; D Y Mason; A I Spriggs
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

2.  Is there a role for radioimmunolocalization in diagnosis of intracranial malignancies?: discussion paper.

Authors:  J T Kemshead; D H Jones; A Goldman; R B Richardson; H B Coakham
Journal:  J R Soc Med       Date:  1984-10       Impact factor: 5.344

3.  Distribution of the Ca (Oxford) antigen in lung neoplasms and non-neoplastic lung tissues.

Authors:  F J Paradinas; G Boxer; K D Bagshawe
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

4.  Monoclonal antibodies against antigens on breast cancer cells.

Authors:  C Stähli; B Takacs; V Miggiano; T Staehelin; H Carmann
Journal:  Experientia       Date:  1985-11-15

5.  Immunohistochemical phenotyping of human solid tumors with monoclonal antibodies in devising biotherapeutic strategies.

Authors:  S K Liao; C Meranda; B P Avner; T Romano; S Husseini; B Kimbro; R K Oldham
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.